DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Raghu G, Johnson WC, Lockhart D et al.
Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study.
Am J Respir Crit Care Med 1999;
159: 1061-1069
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.